Paper10469752
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
Milas L and 5 others. J Natl Cancer Inst, 1999. Cited by 195 papers, by iCite.
Cite this record
ConductScience Library. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. Papers, record 10469752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10469752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclooxygenase Inhibitors | Major topic |
| Isoenzymes | Major topic |
| Prostaglandin-Endoperoxide Synthases | Major topic |
| Pyrazoles | Major topic |
| Radiation-Sensitizing Agents | Major topic |
| Sarcoma, Experimental | Major topic |
| Sulfonamides | Major topic |
| Animals | |
| Cyclooxygenase 2 | |
| Cyclooxygenase 2 Inhibitors | |
| Gamma Rays | |
| Mice | |
| Neovascularization, Pathologic | |
| Benzenesulfonamides |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 10675387 | Re: Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. | https://conductscience.org/library/papers/10675387 |
Source PubMed
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 195 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39886153 | Repurposing radiosensitising medicines for radiotherapy: an overview. | BMJ Oncol | 2024 | https://conductscience.org/library/papers/39886153 | PubMed |
| 32720598 | 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer. | Curr Med Chem | 2020 | https://conductscience.org/library/papers/32720598 | PubMed |
| 27104573 | Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review. | Antioxidants (Basel) | 2016 | https://conductscience.org/library/papers/27104573 | PubMed |
| 26823679 | Repurposing Drugs in Oncology (ReDO)-diclofenac as an anti-cancer agent. | Ecancermedicalscience | 2016 | https://conductscience.org/library/papers/26823679 | PubMed |
| 25371868 | An observational study on the expression of cyclooxygenase-2 in meningioma. | Adv Biomed Res | 2014 | https://conductscience.org/library/papers/25371868 | PubMed |
| 25126707 | Metabolic phenotyping reveals a lipid mediator response to ionizing radiation. | J Proteome Res | 2014 | https://conductscience.org/library/papers/25126707 | PubMed |
| 23289871 | Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model. | BMC Urol | 2013 | https://conductscience.org/library/papers/23289871 | PubMed |
| 21876693 | Targeting the tumor microenvironment: focus on angiogenesis. | J Oncol | 2012 | https://conductscience.org/library/papers/21876693 | PubMed |
| 21532508 | Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial. | J Thorac Oncol | 2011 | https://conductscience.org/library/papers/21532508 | PubMed |
| 20599771 | Targeting inflammatory pathways for tumor radiosensitization. | Biochem Pharmacol | 2010 | https://conductscience.org/library/papers/20599771 | PubMed |
| 19340516 | Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer. | Ir J Med Sci | 2009 | https://conductscience.org/library/papers/19340516 | PubMed |
| 19252746 | COX-2 Inhibition Combined with Radiation Reduces Orthotopic Glioma Outgrowth by Targeting the Tumor Vasculature. | Transl Oncol | 2009 | https://conductscience.org/library/papers/19252746 | PubMed |
| 19000324 | Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2. | J Exp Clin Cancer Res | 2008 | https://conductscience.org/library/papers/19000324 | PubMed |
| 18698028 | Multimodality therapy: potentiation of high linear energy transfer radiation with paclitaxel for the treatment of disseminated peritoneal disease. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18698028 | PubMed |
| 18392637 | The role of COX-2 in rectal cancer treated with preoperative radiotherapy. | Virchows Arch | 2008 | https://conductscience.org/library/papers/18392637 | PubMed |
| 17603773 | Cyclooxygenase-2 expression in human irradiated uveal melanomas. | Int Ophthalmol | 2008 | https://conductscience.org/library/papers/17603773 | PubMed |
| 17511025 | Cyclooxygenase-2 expression after preoperative chemoradiotherapy correlates with more frequent esophageal cancer recurrence. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17511025 | PubMed |
| 17461495 | Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17461495 | PubMed |
| 17428102 | Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? | Drugs | 2007 | https://conductscience.org/library/papers/17428102 | PubMed |
| 17293237 | Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. | Int J Radiat Oncol Biol Phys | 2007 | https://conductscience.org/library/papers/17293237 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10469752
GET https://conductscience.org/api/papers/v1/10469752/cited_by?page=2